InsiderClue
Insiders · Profile

Knotnerus Tim Jasper

Chief Executive Officer at Agomab Therapeutics. Filing since 5 Oct 2026. CIK 0002120886

Company
Date
Role
Action
Shares
Amount
Of holding
AGMB Agomab Therapeutics NV
6 Oct 2026
Chief Executive Officer
Bought
5,000
$43.50K
29.7%
AGMB Agomab Therapeutics NV
5 Oct 2026
Chief Executive Officer
Bought
6,000
$50.88K
55.4%
2 decisions on file.